Cancer Research and Treatment

MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers

Bianka Gurbi, Diána Brauswetter, Kinga Pénzes, Attila Varga, Tibor Krenács, Kornél Dános, Ede Birtalan, László Tamás, Miklós Csala

International Journal of Molecular Sciences.2023; 24(3): 2782. CrossRef

Effects of EGFR gene mutation on stage 3A lung adenocarcinomas in the clinical decision-making process for mediastinal invasive staging

İsmail Ağababaoğlu, Özgür Ömer Yıldız, Hasan Ersöz, Gökçen Şimşek, Yavuz Selim Sanisoğlu, Nurettin Karaoğlanoğlu

Medical Science and Discovery.2022; 9(1): 44. CrossRef

Dual NGS Comparative Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Non-Small Cell Lung Carcinoma (NSCLC)

Laura Buburuzan, Maria-Anca Zamfir (Irofei), Carmen Maria Ardeleanu, Alin Horatiu Muresan, Florina Vasilescu, Ariana Hudita, Marieta Costache, Bianca Galateanu, Alexandra Puscasu, Alexandru Filippi, Natalia Motas

Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC)

Chhanda Das, Madhumita Mukhopadhyay, Srijana Subba, Ashis Kumar Saha, Biswanath Mukhopadhyay

Journal of Laboratory Physicians.2021; 13(01): 029. CrossRef

Application of the conventional and novel methods in testing EGFR variants for NSCLC patients in the last 10 years through different regions: a systematic review

Jasmina Obradovic, Jovana Todosijevic, Vladimir Jurisic

Molecular Biology Reports.2021; 48(4): 3593. CrossRef

RETRACTED ARTICLE: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing

Georgios I. Laliotis, Evangelia Chavdoula, Maria D. Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A. Nair, Arturo Orlacchio, Vasiliki Taraslia, Ioannis Vlachos, Marina Capece, Artemis Hatzigeorgiou, Dario Pa

Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital

Moupali Ghosh, Madhumita Mukhopadhyay, Chhanda Das, Surojit Chatterjee, BidishaGhosh Naskar

Journal of Cancer Research and Therapeutics.2021; 17(6): 1389. CrossRef

Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets

Arutha Kulasinghe, Joanna Kapeleris, Carolina Cooper, Majid Ebrahimi Warkiani, Kenneth O’Byrne, Chamindie Punyadeera

Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma

Dhoha Dhieb, Imen Belguith, Laura Capelli, Elisa Chiadini, Matteo Canale, Sara Bravaccini, Ilhem Yangui, Ons Boudawara, Rachid Jlidi, Tahya Boudawara, Daniele Calistri, Leila Ammar Keskes, Paola Ulivi

Intratumour heterogeneity of p53 expression; causes and consequences

The Journal of Pathology.2019; 249(3): 274. CrossRef

Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non–Small-cell Lung Cancer

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Véronique Hofman, Sandra Lassalle, Coraline Bence, Elodie Long-Mira, Sacha Nahon-Estève, Simon Heeke, Virginie Lespinet-Fabre, Catherine Butori, Marius Ilié, Paul Hofman

EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

Zohra Mraihi, Jihen Ben Amar, Hend Bouacha, Soumaya Rammeh, Lamia Hila

Immunohistochemistry for EGFR Mutation Detection in Non–Small-Cell Lung Cancer

Nina Turnšek Hitij, Izidor Kern, Aleksander Sadikov, Lea Knez, Karmen Stanič, Matjaž Zwitter, Tanja Cufer

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

Aeri Kim, Min Hye Jang, Soo Jung Lee, Young Kyung Bae

Journal of Breast Cancer.2017; 20(2): 150. CrossRef

Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistry

Masami Yoshida, Tadasuke Nagatomo, Takafumi Ohnishi, Mayumi Kawashima, Akira Naitoh, Eiichi Morii

Molecular and Clinical Oncology.2017;[Epub] CrossRef

Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methods

Hua-Lin Kao, Yi-Chen Yeh, Chin-Hsuan Lin, Wei-Fang Hsu, Wen-Yu Hsieh, Hsiang-Ling Ho, Teh-Ying Chou

LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients

Yu Jin Kim, Sungyoul Hong, Minjung Sung, Min Jeong Park, Kyungsoo Jung, Ka-Won Noh, Doo-Yi Oh, Mi-Sook Lee, Ensel Oh, Young Kee Shin, Yoon-La Choi